Literature DB >> 23465661

Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid.

Anne-Kathrin Kienzler, Marta Rizzi, Maike Reith, Stephen L Nutt, Hermann Eibel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23465661     DOI： 10.1016/j.jaci.2013.01.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  14 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  B cell biology: an overview.

Authors:  Hermann Eibel; Helene Kraus; Heiko Sic; Anne-Kathrin Kienzler; Marta Rizzi
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 3.  The role of genomics in common variable immunodeficiency disorders.

Authors:  A-K Kienzler; C E Hargreaves; S Y Patel
Journal:  Clin Exp Immunol       Date:  2017-03-29       Impact factor: 4.330

Review 4.  Advances in basic and clinical immunology in 2013.

Authors:  Javier Chinen; Luigi D Notarangelo; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

5.  B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

Authors:  Alexandra M Miggelbrink; Brent R Logan; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Hisham Abdel-Azim; Susan E Prockop; David Shyr; Hélène Decaluwe; Imelda C Hanson; Alfred Gillio; Blachy J Dávila Saldaña; Hermann Eibel; Gregory Hopkins; Jolan E Walter; Jennifer S Whangbo; Donald B Kohn; Jennifer M Puck; Morton J Cowan; Linda M Griffith; Elie Haddad; Richard J O'Reilly; Luigi D Notarangelo; Sung-Yun Pai
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

Review 6.  Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Authors:  Jacqueline Kerr; Isabella Quinti; Martha Eibl; Helen Chapel; Peter J Späth; W A Carrock Sewell; Abdulgabar Salama; Ivo N van Schaik; Taco W Kuijpers; Hans-Hartmut Peter
Journal:  Front Immunol       Date:  2014-12-12       Impact factor: 7.561

7.  Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity.

Authors:  Katharina L Willmann; Stefanie Klaver; Figen Doğu; Elisangela Santos-Valente; Wojciech Garncarz; Ivan Bilic; Emily Mace; Elisabeth Salzer; Cecilia Domínguez Conde; Heiko Sic; Peter Májek; Pinaki P Banerjee; Gregory I Vladimer; Sule Haskoloğlu; Musa Gökalp Bolkent; Alphan Küpesiz; Antonio Condino-Neto; Jacques Colinge; Giulio Superti-Furga; Winfried F Pickl; Menno C van Zelm; Hermann Eibel; Jordan S Orange; Aydan Ikincioğulları; Kaan Boztuğ
Journal:  Nat Commun       Date:  2014-11-19       Impact factor: 14.919

Review 8.  Regulation of germinal center, B-cell memory, and plasma cell formation by histone modifiers.

Authors:  Kim L Good-Jacobson
Journal:  Front Immunol       Date:  2014-11-19       Impact factor: 7.561

Review 9.  Epigenome-modifying tools in asthma.

Authors:  Peter O Brook; Mark M Perry; Ian M Adcock; Andrew L Durham
Journal:  Epigenomics       Date:  2015-10-07       Impact factor: 4.778

Review 10.  Protein Kinase C δ: a Gatekeeper of Immune Homeostasis.

Authors:  Elisabeth Salzer; Elisangela Santos-Valente; Bärbel Keller; Klaus Warnatz; Kaan Boztug
Journal:  J Clin Immunol       Date:  2016-08-19       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.